26
|
Giaccherini L, Ciammella P, Galaverni M, Manicone M, Renna I, Galeandro M, Timon G, Bellafiore F, Ramundo D, Vigo F, Rosca A, Palmieri T, Ruggieri M, Botti A, Sghedoni R, Cagni E, Orlandi M, Iori M, Russo M, Iotti C. EP-1650 Elderly glioblastoma patients:role of multidimensional assessment of frailty in predicting outcomes. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32070-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
27
|
Cagni E, Botti A, Orlandi M, Sghedoni R, Spezi E, Iori M. PO-0996 A knowledge-based tool to estimate the gain of re-planning strategy for Head and Neck (HN) ART. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31416-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
28
|
Manicone M, Galaverni M, Renna I, Ciammella P, Giaccherini L, Bellafiore F, Timon G, Vigo F, Rosca A, Ramundo D, Galeandro M, Ruggieri M, Palmieri T, Botti A, Sghedoni R, Cagni E, Orlandi M, Russo M, Bonelli C, Pagano M, Iotti C. EP-1248 Stereotactic radiotherapy for brain metastasis and systemic therapies: a safe combination? Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31668-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
29
|
Galli A, Gargano M, Bonizzoni L, Giorgione C, Ludwig N, Maspero F, Orlandi M, Zoia L, Martini M. A multidisciplinary investigation on a pair of Leonardesque canal lock gates. Microchem J 2018. [DOI: 10.1016/j.microc.2018.01.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
30
|
Bacci G, Picci P, Orlandi M, Avella M, Manfrini M, Pignatti G, Dallari D, Manduchi R. Prognostic Value of Serum Alkaline Phosphatase in Osteosarcoma. TUMORI JOURNAL 2018; 73:331-6. [PMID: 3477902 DOI: 10.1177/030089168707300402] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In 163 patients with osteosarcoma of the extremities treated with adjuvant chemotherapy, serum alkaline phosphatase (SAP) levels were evaluated before treatment and successively closely monitored in an attempt to determine whether serum levels of this enzyme had clinical value in predicting the course of the disease. Of 121 patients with elevated preoperative SAP levels, 78 (64%) recurred. Of 42 patients with normal preoperative SAP levels, only 8 (19%) recurred (P < 0.00001). Of the 140 patients locally treated with amputation, SAP returned to normal values in 77 patients; 46 of these (59%) relapsed. Of the 21 patients whose SAP remained elevated after amputation, all but 2 relapsed (90%). Among 119 patients with normal postoperative values of SAP, at the time of relapse SAP resulted elevated in 22 of 41 patients (53%). These data confirm that in osteosarcoma, preoperative SAP levels have a definite value in establishing the prognosis and that posttreatment follow-up examination should include SAP determination, since persistent elevated or increasing values herald the appearance of a recurrence.
Collapse
|
31
|
Bacci G, Avella M, McDonald D, Toni A, Orlandi M, Campanacci M. Serum Lactate Dehydrogenase (LDH) as a Tumor Marker in Ewing's Sarcoma. TUMORI JOURNAL 2018; 74:649-55. [PMID: 3232209 DOI: 10.1177/030089168807400606] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The pretreatment serum lactic acid dehydrogenase (LDH) level of 246 patients with Ewing's sarcoma of bone (47 metastatic and 199 localized at presentation) was examined to evaluate the use of LDH as a tumor marker. The percentage of patients with increased serum LDH levels was significantly higher in the metastatic group than in the group of patients with localized disease (83 % vs 41 %; p < 0.01). In the latter group the relapse rate after treatment with combined therapy was significantly higher in patients with an elevated serum LDH at admission than in those with normal serum levels (68.2 % vs 39.3 %; p < 0.01). After local treatment, in 73 out of 82 patients with an elevated serum LDH at admission the enzyme level normalized whereas in 9 it fell but never reached a normal value. The rate of relapse in these two groups was respectively 64 % and 100 %. The value of serum LDH at the time of recurrence, determined in 62 patients, was elevated in 50 (80.7 %). These data demonstrate that in Ewing's sarcoma of bone pretreatment serum LDH levels have a definitive value in establishing the prognosis and could also be used in evaluating the response to therapy. A persistent elevated value of serum LDH, or an increasing value after a transient normalization, is usually followed by relapse.
Collapse
|
32
|
Ciammella P, Galaverni M, Lattanzi E, Timon G, Renna I, Botti A, Orlandi M, Giaccherini L, Bellafiore F, Iotti C. EP-1365: F-FDG-PET/CT metabolic features as prognostic and predictive factors in lung tumors undergoing SBRT. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31674-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Iori M, Galeandro M, Botti A, Sghedoni R, Ciammella P, Orlandi M, Napoli M, Tanzi S, Pascarella R, Cavuto S, Pisanello A, Russo M, Cagni E, Chiari D, Campioli M, Iotti C. EP-1397: Dose painting guided by diffusion-weighted MRI applied to recurrent glioblastoma: a phase I protocol. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31832-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
34
|
Orlandi M, Ceotto M, Benaglia M. Kinetics versus thermodynamics in the proline catalyzed aldol reaction. Chem Sci 2016; 7:5421-5427. [PMID: 30034680 PMCID: PMC6021756 DOI: 10.1039/c6sc01328g] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2016] [Accepted: 05/06/2016] [Indexed: 01/05/2023] Open
Abstract
In this paper the equilibrium properties of the proline catalyzed aldol reaction was studied. The use of well-established methodologies, like reaction progress kinetic analysis and linear free energy relationship analysis, led to the quantification of the reaction reversibility and to its correlation with the substrate electronic activation. Due to these experimental observations, common computational approaches based on a one way transition state analysis become unsuitable. Therefore, a computational model based on the integration of a system of kinetic differential equations associated to the multiple equilibrium reactions was proposed. Such a model was found to successfully rationalize the chemical and stereochemical outcomes of this paradigmatic reaction for the first time.
Collapse
|
35
|
Orlandi M, De Magnis A, Fanchi A, Maddali Bongi S. FRI0342 Vulvar Histopathological and Immunohistochemical Changes in Patients with Primary Sjögren Syndrome. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
36
|
Orlandi M, Botti A, Cagni E, Orsingher L, Sghedoni R, Patrizia C, Iotti C, Iori M. EP-1707: Tomotherapy dose painting hypofractionated treatments on GBM based on DW-MRI: a feasibility study. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32958-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
37
|
Botti A, Cagni E, Micera R, Nicola S, Orsingher L, Orlandi M, Iotti C, Cozzi L, Iori M. EP-1643: Rapidplan: 'knowledge-based' model with Tomotherapy plans. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32894-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
38
|
Orlandi M, Botti A, Cagni E, Orsingher L, Sghedoni R, Ciammella P, Iotti C, Iori M. PO-0868: A method to define isodose-based structures in Dose Painting treatment of GBM in Tomotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32118-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
39
|
Iori M, Ciammella P, Orlandi M, Chiari D, Campioli M, Orsingher L, Botti A, Sghedoni R, Cagni E, Cavuto S, Pascarella R, Pisanello A, Iotti C. Dose painting by numbers (DPBN) guided by diffusion-weighted MRI applied to recurrent glioblastoma (GBM): An experimental protocol of phase I/II. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
40
|
Orlandi M, Botti A, Cagni E, Sghedoni R, Orsingher L, Ciammella P, Iotti C, Iori M. A feasibility study of tomotherapy dose painting hypofractionated treatments on glioblastoma multiforme (GBM) guided by MRI. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
41
|
Orlandi M, Botti A, Cagni E, Sghedoni R, Orsingher L, Ciammella P, Iotti C, Iori M. A method to define isodose-based structures in dose painting treatment optimization of glioblastoma multiforme tumors (GBM). Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
42
|
Cagni E, Botti A, Micera R, Orsingher L, Orlandi M, Simoni N, Iotti C, Iori M. RE-irradiation (RE-RT) of head and neck cancer (HNC): Dose accumulation using deformable image registration (DIR) and comparison with rigid registration (RIR). Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
43
|
Giovannini L, Orlandi M, Lodato C, Cioffi E, Tenti S, Bardelli M, Talarico R, Guiducci S. One year in review 2015: spondyloarthritis. Clin Exp Rheumatol 2015; 33:769-778. [PMID: 26690889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Accepted: 12/04/2015] [Indexed: 06/05/2023]
Abstract
Spondyloarthritis represents a heterogeneous group of articular inflammatory diseases that share common genetic, clinical and radiological features. Recently, novel insights into the epidemiology, pathogenesis and treatment of these diseases have been provided. Herewith, we provide an overview of the most significant literature contributions published over the year.
Collapse
|
44
|
Valsuani C, Beatini A, Pacetti P, Marcozzi G, Luxardo S, Marchetti V, Tartarini R, Orlandi M, Tofani A, Tagliagambe A, Mambrini A. X-Rays absorption evaluation in cancer patients submitted to cosmeceutical prophylaxis with smoothing emulsion and sun protecion factor cream during radiotherapy. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv348.56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Pacetti P, Beatini A, Muttini M, Tartarini R, Orlandi M, Della Seta R, Pedata M, Mambrini A. Skin parameters evaluation in breast cancer patients during adjuvant chemotherapy. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv347.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
46
|
Orlandi M, Tosi F, Bonsignore M, Benaglia M. Metal-Free Reduction of Aromatic and Aliphatic Nitro Compounds to Amines: A HSiCl3-Mediated Reaction of Wide General Applicability. Org Lett 2015; 17:3941-3. [DOI: 10.1021/acs.orglett.5b01698] [Citation(s) in RCA: 76] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Tinterri C, Gatzemeier W, Costa A, Gentilini MA, Zanini V, Regolo L, Pedrazzoli C, Rondini E, Amanti C, Gentile G, Taffurelli M, Fenaroli P, Tondini C, Sacchetto G, Sismondi P, Murgo R, Orlandi M, Cianchetti E, Andreoli C. Breast-conservative surgery with and without radiotherapy in patients aged 55-75 years with early-stage breast cancer: a prospective, randomized, multicenter trial analysis after 108 months of median follow-up. Ann Surg Oncol 2013; 21:408-15. [PMID: 24197757 DOI: 10.1245/s10434-013-3233-x] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2013] [Indexed: 11/18/2022]
Abstract
OBJECTIVES Breast-conserving therapy (BCT), including postoperative whole breast irradiation (WBI), is generally accepted as the treatment of choice for most patients with early-stage breast cancer. The question whether WBI is mandatory in all patients remains one of the most controversial issues in BCT. To answer this question, a randomized, prospective, multicentre study was launched in January 2001. Primary endpoints of the study were to assess the cumulative incidence of in-breast-recurrences (IBR) and overall survival (OAS) after conservative surgery (BCS) with or without WBI. METHODS From January 2001 until December 2005, 749 patients with unifocal infiltrating breast cancer up to 25 mm, 0-3 positive axillary lymph nodes, no extensive intraductal component or lymphvascular invasion from 11 centres in Italy, were randomly assigned to BCS+WBI (arm 1:373 patients) or BCS alone (arm 2:376 patients). Treatment arms were well balanced in terms of baseline characteristics. Systemic adjuvant therapy was administered according to the institutional policies. Kaplan-Meier method was used for survival analysis and log-rank test to evaluate the difference between the two arms. RESULTS (Last analysis 31.12.2012): After median follow-up of 108 months, 12 (3.4%) IBR were observed in arm 1 and 16 (4.4%) in arm 2. OAS was 81.4% in arm 1 and 83.7% in arm 2. There was no statistically significant difference regarding IBR and death in the two treatment groups. CONCLUSIONS These data are promising and suggest that WBI after BCS can be omitted in selected patients with early stage breast cancer without exposing them to an increased risk of local recurrence and death. Longer follow-up is needed to further consolidate these results.
Collapse
|
48
|
Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava ML, Orlandi M, Bonardi C, Fiorentini ML, Caporali R, Caccialanza R. Disease-related nutritional risk and mortality in systemic sclerosis. Clin Nutr 2013; 33:558-61. [PMID: 24054278 DOI: 10.1016/j.clnu.2013.08.010] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2013] [Revised: 08/23/2013] [Accepted: 08/25/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND & AIMS To evaluate the relationship between mortality and nutritional risk associated with disease activity in Systemic Sclerosis (SSc). METHODS A single-centre prospective cohort study involving 160 SSc outpatients (median age, 62 years [25th-75th, 54-68]). Nutritional risk was assessed by the Malnutrition Universal Screening Tool (MUST), a screening tool that combines anthropometric parameters of nutritional status (body mass index [BMI] and percentage of unintentional weight loss [WL]) with the presence of an "acute disease" (as defined by a disease activity score ≥3 according to Valentini's criteria). RESULTS Prevalence of high nutritional risk (MUST score ≥2) was 24.4% [95%CI, 17.4-31.3]. A low nutritional risk (MUST = 1) was detected in 30% of our study sample. In hazard analysis (median follow-up duration = 46 months [25th-75th percentile, 31-54]), high nutritional risk was significantly associated with mortality (HR = 8.3 [95%CI, 2.1-32.1]). The performance of the model based on nutritional risk including disease activity (Harrell's c = 0.74 [95%CI, 0.59-0.89]) was superior to that based on active disease alone (HR = 6.3 [95%CI, 1.8-21.7]; Harrell's c = 0.68 [95%CI, 0.53-0.84]). Risk scored only by anthropometric parameters (prevalence, 9.4% [95%CI, 4.6-14.2]) was not associated with mortality: HR = 2.8 [95%CI, 0.6-13.2]. CONCLUSIONS In SSc outpatients MUST significantly predicts mortality. The combined assessment of nutritional parameters and disease activity significantly improves the evaluation of mortality risk. Disease-related nutritional risk screening should be systematically included in the clinical workup of every SSc patient.
Collapse
|
49
|
Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava M, Orlandi M, Bonardi C, Quarleri L, Cappello S, Caporali R, Caccialanza R. PP115-MON SERUM PREALBUMIN IS A PREDICTOR OF MORTALITY IN SYSTEMIC SCLEROSIS OUTPATIENTS. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60426-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava M, Orlandi M, Bonardi C, Quarleri L, Cappello S, Caporali R, Caccialanza R. PP131-SUN DISEASE-RELATED NUTRITIONAL RISK AND MORTALITY IN SYSTEMIC SCLEROSIS. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60176-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|